Turner Syndrome



Study to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone Deficiency or Ullrich-Turner Syndrome


Condition:   Growth Disorders
Intervention:   Drug: Zomacton
Sponsor:   Ferring Pharmaceuticals
Not yet recruiting


A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome


Condition:   Turner Syndrome
Interventions:   Biological: PEG-rhGH low dose;   Biological: PEG-rhGH high dose;   Other: Non-treatment control group
Sponsors:   GeneScience Pharmaceuticals Co., Ltd.;   Beijing Children's Hospital;   The First Affiliated Hospital with Nanjing Medical University;   Shanghai Children's Hospital;   Children's Hospital of Fudan University;   Xinhua Hospital, Shanghai Jiao Tong University School of Medicine;   First Hospital of Jilin University;   Jiangxi Province Children's Hospital;   Affiliated Hospital of Jiangnan University;   The Children's Hospital of Zhejiang University School of Medicine
Recruiting


Turner Syndrome Research Network Registry


Condition:   Turner Syndrome
Intervention:   Genetic: Research genetic tests
Sponsor:   The University of Texas Health Science Center, Houston
Recruiting


Health, Fitness, and Quality of Life in Adolescent Girls With Turner Syndrome


Conditions:   Turner Syndrome;   Turner Syndrome Mosaicism, 45, X/46, XX or XY;   Turner Syndrome Mosaicism 46,X,I(X)(Q10)/45,X;   Turner Syndrome Karyotype 46,X With Abnormal Sex Chromosome , Except I(Xq)
Intervention:   Other: No intervention
Sponsor:   University of Colorado, Denver
Recruiting


Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Women With Primary Ovarian Insufficiency (POI)


Condition:   Primary Ovarian Insufficiency
Interventions:   Biological: Placebo transplantation;   Biological: HUC-MSCs transplantation
Sponsors:   Chinese Academy of Sciences;   The Third Affiliated Hospital of Guangzhou Medical University
Recruiting


Ovarian Laparoscopic In Vivo Activation of Ovary for Premature Ovarian Insufficiency


Condition:   Primary Ovarian Insufficiency
Intervention:   Device: OLIVA device
Sponsor:   Hadassah Medical Organization
Not yet recruiting


Single Center, Prospective Controlled Pilot Study of the OvaPrime Procedure


Conditions:   Primary Ovarian Insufficiency;   Poor Ovarian Response
Intervention:   Other: OvaPrime Treatment
Sponsor:   OvaScience, Inc.
Recruiting


Hormone Replacement for Premature Ovarian Insufficiency


Condition:   Primary Ovarian Insufficiency
Interventions:   Drug: Hormone Replacement Therapy;   Drug: Combined Oral Contraceptives
Sponsor:   University of Pennsylvania
Recruiting


Primary Ovarian Insufficiency, Polycystic Ovary Syndrome & the CardiOvascular Risk Profile


Condition:   Cardiovascular Diseases
Intervention:   Procedure: cardiovascular screening
Sponsors:   UMC Utrecht;   VU University Medical Center;   Erasmus Medical Center
Recruiting


AVAST Anomalies Vasculaires Associées au Syndrome de Turner (Vascular Abnormalities Associated With Turner Syndrome)


Conditions:   Turner Syndrome;   Peripheral Angiopathy;   Vascular Malformation;   Lymphedema
Intervention:   Procedure: Echo doppler
Sponsor:   University Hospital, Strasbourg, France
Recruiting


Deep Reading as a Contemplative Practice for Women With Primary Ovarian Insufficiency


Condition:   Ovarian Insufficiency
Intervention:   Other: Group reading and discussion
Sponsors:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   National Institute on Deafness and Other Communication Disorders (NIDCD)
Enrolling by invitation


Risk of Diabetes in Young Turner Syndrome Patients


Condition:   Turner Syndrome
Intervention:  
Sponsors:   Children's Hospital Medical Center, Cincinnati;   National Center for Advancing Translational Science (NCATS)
Completed


Observational Epidemiologic Study in Women With Premature Ovarian Failure (POF)


Condition:   Primary Ovarian Insufficiency
Intervention:  
Sponsor:   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Recruiting


A Clinical Study to Assess the Efficacy and Safety of DA-3002


Condition:   Turner's Syndrome
Interventions:   Drug: DA-3002;   Drug: Genotropin®
Sponsor:   Dong-A ST Co., Ltd.
Active, not recruiting


Growth Response in Girls With Turner Syndrome


Conditions:   Genetic Disorder;   Turner Syndrome
Intervention:   Drug: somatropin
Sponsor:   Novo Nordisk A/S
Completed


Induction of Puberty With 17-beta Estradiol in Girls With Turner Syndrome


Conditions:   Genetic Disorder;   Turner Syndrome
Intervention:   Drug: 17-beta estradiol
Sponsor:   Novo Nordisk A/S
Completed


Social Cognition and Turner Syndrome


Condition:   Turner Syndrome
Intervention:   Other: Evaluation of 45,X Turner syndrome patients
Sponsor:   Assistance Publique - Hôpitaux de Paris
Completed


Use of Somatropin in Turner Syndrome


Conditions:   Genetic Disorder;   Turner Syndrome
Intervention:   Drug: somatropin
Sponsor:   Novo Nordisk A/S
Completed


Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome


Conditions:   Genetic Disorder;   Turner Syndrome
Interventions:   Drug: somatropin;   Drug: oestrogen
Sponsor:   Novo Nordisk A/S
Completed


Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome


Condition:   Turner Syndrome
Intervention:   Drug: somatotropin
Sponsors:   Rebecca Knickmeyer Santelli, PhD;   Pfizer
Completed


Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years


Condition:   Turner's Syndrome
Interventions:   Other: 0.15 IU/kg/day GH;   Other: 0.1 IU/kg/day GH
Sponsor:   Merck KGaA
Completed


Dry Eye in Women With Turner Syndrome and Women With Premature Ovarian Failure


Conditions:   Turner Syndrome;   Ovarian Failure, Premature;   Sex Chromosome Aberrations;   Menopause;   Perimenopause
Intervention:  
Sponsor:   National Eye Institute (NEI)
Completed


Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome


Condition:   Turner Syndrome
Intervention:   Drug: Humatrope
Sponsor:   Eli Lilly and Company
Completed


Turner Syndrome: Genotype and Phenotype


Condition:   Turner's Syndrome
Intervention:  
Sponsors:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   National Human Genome Research Institute (NHGRI)
Completed


The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome


Conditions:   Dwarfism;   Turner's Syndrome
Interventions:   Drug: Humatrope;   Drug: Oxandrolone
Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Completed

Refine Your Search Advanced Search